+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sequencing Reagents Market - Global Forecast 2026-2032- Product Image
Sequencing Reagents Market - Global Forecast 2026-2032- Product Image
Sale

Sequencing Reagents Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012646
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sequencing Reagents Market is projected to reach USD 11.58 Billion in 2026. It is expected to continue growing at a CAGR of 18.12%, reaching USD 31.59 Billion by 2032.

Sequencing reagents are the recurring consumables that enable next-generation sequencing workflows, including library preparation enzymes, adapters, primers, buffers, cluster generation chemistry, flow cell reagents, and signal detection materials. Demand is structurally linked to rising sequencing volume in oncology, infectious disease surveillance, reproductive health, pharmacogenomics, agricultural genomics, and population-scale research.

Verified industry signals show sustained adoption: the National Human Genome Research Institute documents that genome sequencing costs have fallen from the multi-billion-dollar Human Genome Project era to below USD 1,000 for many whole-genome workflows, while high-throughput platforms continue to target lower per-genome reagent economics. This cost compression makes reagent performance, lot consistency, automation compatibility, and supply reliability central purchasing criteria for laboratories moving from discovery research to clinical-grade genomics.

Transformative Shifts in Sequencing Reagents

The sequencing reagents landscape is shifting from research-centric purchasing toward clinical, biopharma, and public-health applications that require validated chemistry and traceable quality systems. Short-read sequencing remains widely used for high-throughput applications, while long-read, single-cell, spatial, and methylation sequencing workflows are expanding reagent requirements for specialized enzymes, barcoding chemistry, and high-integrity sample preparation.

Three verified shifts are reshaping competition: regulated clinical testing is raising expectations for reproducibility; decentralized sequencing is increasing demand for simplified kits; and multiomics is pulling sequencing reagents into integrated DNA, RNA, epigenomic, proteogenomic, and spatial biology workflows. Suppliers that combine chemistry innovation with instrument-agnostic workflow support are better positioned as laboratories standardize scalable protocols and seek lower failure rates across complex sample types.

Cumulative Impact of AI on Sequencing Reagents

Artificial intelligence is compounding the value of sequencing reagents by improving base calling, run quality prediction, variant interpretation, error correction, contamination detection, and workflow optimization. AI-enabled analysis does not replace wet-lab chemistry; it increases the need for cleaner libraries, lower bias, improved read accuracy, and standardized reagent performance because computational models depend on high-quality input data.

In practice, AI is accelerating reagent development through enzyme engineering, primer design, adaptive sampling, anomaly detection, and digital quality control. Peer-reviewed tools such as DeepVariant have demonstrated that machine learning can improve variant calling accuracy, while nanopore and high-throughput sequencing workflows increasingly use algorithmic signal processing. The cumulative result is tighter integration between chemistry, instruments, software, and bioinformatics, making reagent consistency a foundational input for reliable AI-assisted genomics.

Regional Insights Across Major Markets

North America remains a leading sequencing reagents region because the United States and Canada combine academic genomics infrastructure, biopharma R&D, clinical laboratory networks, and federal research programs such as NIH-supported genomics initiatives. Europe benefits from coordinated health-data and genomics programs across the European Union, the United Kingdom, Germany, France, Italy, and Spain, with regulatory emphasis on quality, privacy, clinical evidence, and in vitro diagnostic compliance.

Asia-Pacific is expanding through national genome programs, cancer research, reproductive health testing, rare disease studies, agricultural genomics, and growing sequencing capacity in China, India, Japan, South Korea, Australia, and ASEAN economies. Latin America, led by Brazil and Mexico, is increasing adoption through infectious disease surveillance, academic genomics, oncology research, and food and agricultural applications. The Middle East is supported by GCC precision medicine investments and national health transformation programs, while Africa’s demand is tied to pathogen surveillance, population genomics, antimicrobial resistance monitoring, and capacity-building partnerships supported by public-health agencies and research networks.

Strategic Group Insights

G7 economies anchor substantial demand for high-quality sequencing reagents because they host advanced pharmaceutical research, reference laboratories, cancer centers, public-health sequencing programs, and academic genomics hubs. The European Union adds procurement scale, cross-border research coordination, and harmonized regulatory pathways, while NATO countries increasingly recognize genomic surveillance as part of biosecurity, biodefense readiness, and public-health preparedness.

BRICS markets are important adoption engines as China, India, Brazil, Russia, and South Africa expand local sequencing capacity, infectious disease monitoring, agricultural genomics, and more representative genomic databases. ASEAN countries are building regional momentum through pathogen monitoring, reproductive health, oncology research, and crop and aquaculture genomics. GCC countries are notable for population genomics and precision medicine investments, which favor clinically reliable reagents, automated workflows, accredited laboratory practices, and secure supply chains for long-term national programs.

Country-Level Sequencing Reagents Insights

The United States is the largest innovation and adoption hub, supported by NIH funding, FDA-regulated diagnostics, biopharma demand, public-health sequencing, and the All of Us Research Program’s one-million-participant goal. Canada contributes through national genomics networks and precision health initiatives, while Mexico and Brazil are scaling sequencing for public health, cancer research, inherited disease, agriculture, and pathogen surveillance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine strong clinical research with national genomics programs, oncology sequencing, rare disease initiatives, and molecular diagnostics adoption, while Russia maintains scientific capacity despite procurement and cross-border supply complexity. China continues to scale high-throughput sequencing across clinical research, reproductive health, oncology, and agriculture; India is broadening genomic medicine through initiatives such as GenomeIndia and expanding infectious disease and rare disease capabilities; Japan applies sequencing in cancer, rare disease, pharmacogenomics, and aging-related research; Australia supports national genomic medicine networks and public-health genomics; and South Korea advances clinical genomics, precision oncology, infectious disease monitoring, and technology-enabled hospital adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize reagent reliability, regulatory documentation, and workflow compatibility across short-read, long-read, targeted, whole-genome, RNA, methylation, and single-cell sequencing applications. Differentiation should focus on reduced input requirements, faster library preparation, lower duplication rates, improved GC coverage, contamination controls, automation-ready formats, and validated performance across formalin-fixed, low-biomass, and degraded samples.

Commercial teams should align product portfolios with clinical validation, biopharma outsourcing, public-health surveillance, agrigenomics, and population genomics demand. Supply-chain resilience is essential: dual sourcing of critical raw materials, regional inventory buffers, cold-chain discipline, and transparent quality metrics can reduce disruption risk. Partnerships with instrument providers, cloud bioinformatics platforms, accredited laboratories, and translational research networks can also increase workflow integration, customer retention, and confidence in reproducible sequencing outcomes.

Research Methodology

This executive summary is based on a structured review of verified public sources, regulatory information, peer-reviewed genomics literature, public institutional disclosures, and recognized authorities including NIH, NHGRI, FDA, OECD, WHO, national genome programs, and public-health agencies. Insights were triangulated across technology adoption, clinical use cases, regional policy, AI-enabled genomics, and supply-chain indicators.

The methodology emphasizes data-backed interpretation rather than unsupported market sizing, market share, or forecasting. Evidence was assessed for source credibility, recency, applicability to sequencing reagents, and consistency across independent references. Qualitative findings were organized by technology shift, AI impact, geography, strategic groups, and country-level demand drivers to support executive decision-making in sequencing consumables and genomics workflow strategy.

Conclusion

Sequencing reagents are becoming a strategic layer of the genomics value chain as sequencing moves deeper into clinical care, pharmaceutical research, public health, agriculture, and population-scale programs. Cost declines have broadened access, but customers increasingly evaluate suppliers on reproducibility, documentation, automation compatibility, sample-type flexibility, and end-to-end workflow performance.

The next phase of adoption will be shaped by AI-enabled analytics, multiomics integration, regional genomics investments, public-health surveillance, and stronger quality expectations. Organizations that deliver robust chemistry, secure supply, and clinically credible support will be best positioned to capture durable demand in the global sequencing reagents market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sequencing Reagents Market, by Product Type
7.1. Introduction
7.2. Adapters And Tags
7.3. Buffers And Solutions
7.4. Labeling Reagents
7.5. Nucleotides
7.6. Polymerases And Enzymes
7.6.1. Dna Polymerases
7.6.2. Ligases
7.6.3. Reverse Transcriptases
8. Sequencing Reagents Market, by Technology
8.1. Introduction
8.2. Next-Generation Sequencing
8.3. Sanger Sequencing
8.4. Third-Generation Sequencing
9. Sequencing Reagents Market, by Sample Type
9.1. Introduction
9.2. DNA Samples
9.3. RNA Samples
9.4. Cell Free DNA
10. Sequencing Reagents Market, by Application
10.1. Introduction
10.2. Metagenomics Sequencing
10.3. RNA Sequencing
10.4. Targeted Sequencing
10.5. Whole Genome Sequencing
11. Sequencing Reagents Market, by End User
11.1. Introduction
11.2. Academic Research
11.3. Contract Research Organizations
11.4. Healthcare And Diagnostic Laboratories
11.5. Pharmaceutical And Biotechnology Companies
12. Sequencing Reagents Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Sequencing Reagents Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Sequencing Reagents Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 10x Genomics Inc
16.2. Agilent Technologies Inc
16.3. BGI Genomics Co Ltd
16.4. Bio-Rad Laboratories Inc
16.5. Danaher Corp
16.6. Element Biosciences Inc
16.7. Eurofins Scientific SE
16.8. Fulgent Genetics Inc
16.9. GenScript Biotech Corp
16.10. Illumina Inc
16.11. LGC Limited
16.12. MGI Tech Co Ltd
16.13. NeoGenomics Laboratories Inc
16.14. Novogene Co Ltd
16.15. Oxford Nanopore Technologies PLC
16.16. Pacific Biosciences of California Inc
16.17. Paragon Genomics Inc
16.18. Promega Corp
16.19. Psomagen Inc
16.20. QIAGEN NV
16.21. Revvity Inc
16.22. Singular Genomics Systems Inc
16.23. SOPHiA GENETICS SA
16.24. Takara Bio Inc
16.25. Thermo Fisher Scientific Inc
16.26. Twist Bioscience Corp
16.27. Ultima Genomics Inc
List of Figures
FIGURE 1. GLOBAL SEQUENCING REAGENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SEQUENCING REAGENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SEQUENCING REAGENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SEQUENCING REAGENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SEQUENCING REAGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ADAPTERS AND TAGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ADAPTERS AND TAGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ADAPTERS AND TAGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BUFFERS AND SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BUFFERS AND SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BUFFERS AND SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LABELING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LABELING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LABELING REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL NUCLEOTIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL POLYMERASES AND ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL POLYMERASES AND ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL POLYMERASES AND ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DNA POLYMERASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DNA POLYMERASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DNA POLYMERASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LIGASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LIGASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL LIGASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL THIRD-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL THIRD-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL THIRD-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DNA SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DNA SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DNA SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL RNA SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL RNA SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL RNA SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CELL FREE DNA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CELL FREE DNA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CELL FREE DNA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL METAGENOMICS SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL METAGENOMICS SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL METAGENOMICS SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HEALTHCARE AND DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HEALTHCARE AND DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HEALTHCARE AND DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 82. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 84. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 85. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 86. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 87. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 88. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 105. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 106. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 107. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 108. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. NATO SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. NATO SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. NATO SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 121. NATO SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 122. NATO SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 123. NATO SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 124. NATO SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. G7 SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. G7 SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. G7 SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 128. G7 SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 129. G7 SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 130. G7 SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. G7 SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. BRICS SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. BRICS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. BRICS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 135. BRICS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 136. BRICS SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 137. BRICS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. BRICS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 148. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 149. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 151. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. GCC SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GCC SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. GCC SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 156. GCC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 157. GCC SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 158. GCC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. GCC SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 161. CHINA SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 162. CHINA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. CHINA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 164. CHINA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 165. CHINA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 166. CHINA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. CHINA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 169. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 170. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 171. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 173. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. JAPAN SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 176. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 178. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 180. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. INDIA SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. INDIA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. INDIA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 185. INDIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. INDIA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 187. INDIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. INDIA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. GERMANY SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 190. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 192. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 193. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 194. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 197. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 199. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 201. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 206. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 208. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. FRANCE SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 211. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 213. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 214. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 215. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 220. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 221. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 222. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. ITALY SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. ITALY SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. ITALY SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 227. ITALY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. ITALY SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 229. ITALY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. ITALY SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. CANADA SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. CANADA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 233. CANADA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 234. CANADA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 235. CANADA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 236. CANADA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. CANADA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. RUSSIA SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 241. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 243. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 248. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 249. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 250. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. MEXICO SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 254. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 255. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 257. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 258. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. SPAIN SEQUENCING REAGENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 261. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2017-2032 (USD MILLION)
TABLE 262. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 264. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 265. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. GLOBAL SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 267. GLOBAL SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • 10x Genomics Inc
  • Agilent Technologies Inc
  • BGI Genomics Co Ltd
  • Bio-Rad Laboratories Inc
  • Danaher Corp
  • Element Biosciences Inc
  • Eurofins Scientific SE
  • Fulgent Genetics Inc
  • GenScript Biotech Corp
  • Illumina Inc
  • LGC Limited
  • MGI Tech Co Ltd
  • NeoGenomics Laboratories Inc
  • Novogene Co Ltd
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc
  • Paragon Genomics Inc
  • Promega Corp
  • Psomagen Inc
  • QIAGEN NV
  • Revvity Inc
  • Singular Genomics Systems Inc
  • SOPHiA GENETICS SA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp
  • Ultima Genomics Inc

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.58 Billion
Forecasted Market Value ( USD ) by 2032 $ 31.59 Billion
Compound Annual Growth Rate18.1%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Sequencing Reagents - Global Strategic Business Report - Product Image

Sequencing Reagents - Global Strategic Business Report

  • Report
  • 428 Pages
  • Global
From
Sequencing Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Sequencing Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 182 Pages
  • Global
From
Sequencing Reagents Market Report 2026 - Product Image

Sequencing Reagents Market Report 2026

  • Report
  • 250 Pages
  • Global
From
2025 Global Forecast for Sequencing Reagents Kits Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Sequencing Reagents Kits Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Genomics Market - Global Forecast 2026-2032 - Product Image

Genomics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From

About the Sequencing Reagents Market

The Sequencing Reagents market within the context of Genomics is a rapidly growing industry. It is driven by the increasing demand for sequencing technologies and the need for reagents to support them. Sequencing reagents are used to prepare samples for sequencing, to amplify DNA, and to detect and quantify the results. They are essential components of the sequencing process and are used in a variety of applications, including gene expression analysis, genotyping, and whole genome sequencing. The market is highly competitive, with a number of companies offering a range of products and services. These include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and Qiagen. These companies are well-established in the market and have a strong presence in the genomics industry. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.